117 related articles for article (PubMed ID: 37751625)
41. Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity.
Tangye SG;
J Allergy Clin Immunol; 2023 Apr; 151(4):818-831. PubMed ID: 36522221
[TBL] [Abstract][Full Text] [Related]
42. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
Argenziano MG; Bruce SL; Slater CL; Tiao JR; Baldwin MR; Barr RG; Chang BP; Chau KH; Choi JJ; Gavin N; Goyal P; Mills AM; Patel AA; Romney MS; Safford MM; Schluger NW; Sengupta S; Sobieszczyk ME; Zucker JE; Asadourian PA; Bell FM; Boyd R; Cohen MF; Colquhoun MI; Colville LA; de Jonge JH; Dershowitz LB; Dey SA; Eiseman KA; Girvin ZP; Goni DT; Harb AA; Herzik N; Householder S; Karaaslan LE; Lee H; Lieberman E; Ling A; Lu R; Shou AY; Sisti AC; Snow ZE; Sperring CP; Xiong Y; Zhou HW; Natarajan K; Hripcsak G; Chen R
BMJ; 2020 May; 369():m1996. PubMed ID: 32471884
[TBL] [Abstract][Full Text] [Related]
43. COVID-19 Disease in Presenting to the Pediatric Emergency Department: A Multicenter Study of 8886 Cases.
Duman M; Şık N; Tekşam Ö; Akça H; Kurt F; Çağlar AA; Yıldız LA; Taşar MA; Fidancı İ; Yayla BCC; Yılmaz D; Güngör E; Demir Ş; Çokuğraş H; Cebeci SO; Önal P; Saz EU; Yurtseven A; Uysalol M; Yıldız R; Gümüş S; Bal A; Bayturan SŞ; Zengin N; Atik S; Çiftdoğan DY; Berksoy E; Çiçek A; Şahin S; Kızıl MC; Kara Y; Apa H; Ulusoy E; Kara AA; Yesil E; Erdem M; Turan C; Arslanoglu S; Duyu M; Besli GE; Arslan G; Oflu AT; Çeleğen M; Buldu E; Pişkin İE; Kardeş H; Yılmaz HL; Yıldızdaş D; Gökulu G; Çay P; Özer U; Güleryüz OD; Çolak Ö; Güneysu ST
Am J Emerg Med; 2022 Sep; 59():133-140. PubMed ID: 35849960
[TBL] [Abstract][Full Text] [Related]
44. Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies.
Milota T; Smetanova J; Bartunkova J
Pathogens; 2023 Jan; 12(1):. PubMed ID: 36678457
[TBL] [Abstract][Full Text] [Related]
45. Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran.
Goshayeshi L; Akbari Rad M; Bergquist R; Allahyari A; Hashemzadeh K; ; Hoseini B
BMC Infect Dis; 2021 Jul; 21(1):656. PubMed ID: 34233638
[TBL] [Abstract][Full Text] [Related]
46. Predictors of Intensive Care Unit Admission among Hospitalized COVID-19 Patients in a Large University Hospital in Tehran, Iran.
Hatami H; Soleimantabar H; Ghasemian M; Delbari N; Aryannezhad S
J Res Health Sci; 2021 Feb; 21(1):e00510. PubMed ID: 34024768
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
[TBL] [Abstract][Full Text] [Related]
48. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
[TBL] [Abstract][Full Text] [Related]
49. Factors associated with hospital and intensive care admission in paediatric SARS-CoV-2 infection: a prospective nationwide observational cohort study.
Uka A; Buettcher M; Bernhard-Stirnemann S; Fougère Y; Moussaoui D; Kottanattu L; Wagner N; Zimmermann P; Ritz N;
Eur J Pediatr; 2022 Mar; 181(3):1245-1255. PubMed ID: 34845526
[TBL] [Abstract][Full Text] [Related]
50. Children with SARS-CoV-2 infection during the novel coronaviral disease (COVID-19) outbreak in Iran: an alarming concern for severity and mortality of the disease.
Mamishi S; Pourakbari B; Mehdizadeh M; Navaeian A; Eshaghi H; Yaghmaei B; Hosseinpour Sadeghi R; Poormohammadi S; Mahmoudieh Y; Mahmoudi S
BMC Infect Dis; 2022 Apr; 22(1):382. PubMed ID: 35428202
[TBL] [Abstract][Full Text] [Related]
51. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
52. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
53. Clinical course of coronavirus disease-2019 in pregnancy.
Pereira A; Cruz-Melguizo S; Adrien M; Fuentes L; Marin E; Perez-Medina T
Acta Obstet Gynecol Scand; 2020 Jul; 99(7):839-847. PubMed ID: 32441332
[TBL] [Abstract][Full Text] [Related]
54. SARS-CoV-2 T Cell Response in Severe and Fatal COVID-19 in Primary Antibody Deficiency Patients Without Specific Humoral Immunity.
Steiner S; Schwarz T; Corman VM; Gebert L; Kleinschmidt MC; Wald A; Gläser S; Kruse JM; Zickler D; Peric A; Meisel C; Meyer T; Staudacher OL; Wittke K; Kedor C; Bauer S; Besher NA; Kalus U; Pruß A; Drosten C; Volk HD; Scheibenbogen C; Hanitsch LG
Front Immunol; 2022; 13():840126. PubMed ID: 35359967
[TBL] [Abstract][Full Text] [Related]
55. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
[TBL] [Abstract][Full Text] [Related]
56. Clinical characteristics of 116 hospitalized patients with COVID-19 in Wuhan, China: a single-centered, retrospective, observational study.
Xiong S; Liu L; Lin F; Shi J; Han L; Liu H; He L; Jiang Q; Wang Z; Fu W; Li Z; Lu Q; Chen Z; Ding S
BMC Infect Dis; 2020 Oct; 20(1):787. PubMed ID: 33092539
[TBL] [Abstract][Full Text] [Related]
57. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
58. SARS-CoV-2 infection in children, clinical characteristics, diagnostic findings and therapeutic interventions at a tertiary care center in Riyadh, Saudi Arabia.
Alharbi M; Kazzaz YM; Hameed T; Alqanatish J; Alkhalaf H; Alsadoon A; Alayed M; Hussien SA; Shaalan MA; Al Johani SM
J Infect Public Health; 2021 Apr; 14(4):446-453. PubMed ID: 33765595
[TBL] [Abstract][Full Text] [Related]
59. Rethinking immunologic risk: a retrospective cohort study of severe SARS-CoV-2 infections in individuals with congenital immunodeficiencies.
Nguyen AA; Habiballah SB; LaBere B; Day-Lewis M; Elkins M; Al-Musa A; Chu A; Jones J; Fried AJ; McDonald D; van Konijnenburg DPH; Rockowitz S; Sliz P; Oettgen HC; Schneider LC; MacGinnitie A; Bartnikas LM; Platt CD; Ohsumi TK; Chou J
medRxiv; 2023 Jun; ():. PubMed ID: 37333367
[TBL] [Abstract][Full Text] [Related]
60. Role of serology tests in COVID-19 non-hospitalized patients: A cross-sectional study.
Haghi Ashtiani MT; Sadeghi Rad P; Asnaashari K; Shahhosseini A; Berenji F; Mamishi S
PLoS One; 2022; 17(4):e0266923. PubMed ID: 35421183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
